HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Autoimmune enteropathy].

Abstract
Autoimmune enteropathy (AIE) is characterized by protracted diarrhea, malabsorption, immunomediated damage to the intestinal mucosa, and unresponsiveness to changes in diet. The disease is mainly manifested in the small intestine. Lymphocyte deposits are present on the mucous membrane, and anti-enterocyte or anti-goblet cell antibodies have been described in the majority of affected persons. AIE occurs primarily in infants. Immunosuppressive drugs have been used with varying success. The prognosis of AlE is dependent on the degree of severity of the damage to the intestinal mucosa and extraintestinal symptoms and diseases associated therewith.
AuthorsUrpo Kinnunen, Katri Vuopala, Katri Kaukinen
JournalDuodecim; laaketieteellinen aikakauskirja (Duodecim) Vol. 131 Issue 6 Pg. 533-40 ( 2015) ISSN: 0012-7183 [Print] Finland
Vernacular TitleAutoimmuunienteropatia.
PMID26237896 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Immunosuppressive Agents
Topics
  • Autoimmune Diseases (immunology, pathology, prevention & control)
  • Diarrhea (etiology)
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • Intestinal Mucosa (pathology)
  • Intestine, Small (pathology)
  • Malabsorption Syndromes (immunology, pathology, prevention & control)
  • Prognosis
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: